Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions

@article{JohnHStewart2005IntraperitonealHC,
  title={Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions},
  author={IV JohnH.Stewart and Perry Shen and E. A. Levine},
  journal={Annals of Surgical Oncology},
  year={2005},
  volume={12},
  pages={765-777}
}
Natural history studies have shown that peritoneal carcinomatosis is uniformly fatal, with a median survival in the range of approximately 6 months. For more than a decade, a handful of centers have pursued aggressive intraperitoneal cytoreductive surgery combined with intraperitoneal hyperthermic chemotherapy as an alternative approach to this disease. Strict selection criteria, variation in intraperitoneal chemotherapy, and the vagaries of what represents “cytoreductive surgery” make many of… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 57 extracted citations

Advances in clinical research and management of diffuse peritoneal mesothelioma.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer • 2007
View 5 Excerpts
Highly Influenced

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group • 2016
View 2 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 101 references

Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437–44

Y Yonemura
1996
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…